EMA Prepares For Biosimilar Reference Data From Non-EU Sources; U.S. Input Vital
This article was originally published in The Pink Sheet Daily
Executive Summary
The EMA is preparing to accept data from non-EU sourced reference products for biosimilars, but suggests U.S. co-operation is essential to boost global development.